Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614613 · ClinicalTrials.gov registry record · NA
Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT01614613 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 146 participants.
The verdict
NCT01614613, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this study was to test the performance of an investigational Bayer Blood Glucose (BG) meter and five additional Blood Glucose Monitoring Systems (BGMSs). The goal was to obtain glucose samples from subjects with diabetes across the meter operating ranges. A capillary sample was collected from each subject at 3 different times during the visit to obtain natural capillary blood samples with a range of glucose concentrations. Some blood samples were glycolyzed to lower the glucose concentration levels and glucose solution was added to other samples to raise glucose concentration levels. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer). All lancings and testing were performed by study staff.
Interventions
- DEVICE Bayer G3 / Tatsu System
- DEVICE Accu-Chek® Aviva Nano Meter/Accu-Chek® Aviva Test Strips
- DEVICE Freestyle Lite® Meter and Test Strips with ZipwikTM tabs
- DEVICE OneTouch® Ultra®2 / OneTouch® Ultra® Blue Test Strips
- DEVICE One Touch® VerioTM Pro/One Touch® VerioTM Test Strips
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01614613
The ClinicalTrials.gov registry entry for NCT01614613 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bayer G3 / Tatsu System is the first listed.
NCT01614613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01614613 about?
NCT01614613 is a clinical study titled "Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting". The purpose of this study was to test the performance of an investigational Bayer Blood Glucose (BG) meter and five additional Blood Glucose Monitoring Systems (BGMSs). The goal was to obtain glucose samples from subjects with diabetes across the meter operating ranges. A capillary sample was collec...
What is the current status of trial NCT01614613?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2012-05. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01614613?
The interventions under investigation include: Bayer G3 / Tatsu System (DEVICE), Accu-Chek® Aviva Nano Meter/Accu-Chek® Aviva Test Strips (DEVICE), Freestyle Lite® Meter and Test Strips with ZipwikTM tabs (DEVICE), OneTouch® Ultra®2 / OneTouch® Ultra® Blue Test Strips (DEVICE), One Touch® VerioTM Pro/One Touch® VerioTM Test Strips (DEVICE).
Who is sponsoring clinical trial NCT01614613?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.